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Online ethics: where will the interface 
of mental health and the internet lead us?
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Michael Berk3,4,7,8,9 and Trisha Suppes1,2
Abstract 
While e-health initiatives are poised to revolutionize delivery and access to mental health care, conducting clinical 
research online involves specific contextual and ethical considerations. Face-to-face psychosocial interventions can 
at times entail risk and have adverse psychoactive effects, something true for online mental health programs too. 
Risks associated with and specific to internet psychosocial interventions include potential breaches of confidentiality 
related to online communications (such as unencrypted email), data privacy and security, risks of self-selection and 
self-diagnosis as well as the shortcomings of receiving psychoeducation and treatment at distance from an imper-
sonal website. Such ethical issues need to be recognized and proactively managed in website and study design as 
well as treatment implementation. In order for online interventions to succeed, risks and expectations of all involved 
need to be carefully considered with a focus on ethical integrity.
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
E-health initiatives are poised to revolutionize delivery 
and access to mental health care around the world. For 
example, available applications focusing on assessment or 
intervention for adults with depression or anxiety (Chris-
tensen et al. 2014; Griffiths et al. 2010) embody consider-
able strengths such as global accessibility, reduced cost, 
consumer interactivity, and potential for personaliza-
tion (Lal and Adair 2014). While moving mental health 
assessment and intervention online transforms the land-
scape of service provision, it also warrants ethical con-
siderations that differ from those in traditional, in-office, 
face-to-face sessions. Conducting clinical research within 
online platforms delivering mental health care often 
necessitates an even more careful approach to ensuring 
ethical principles are upheld. While it can be argued that 
delivery online involves a similar ethical framework to 
face-to-face, the nuance of this is quite different in the 
online milieu.
This paper examines the unique challenges and eth-
ics of overseeing a global, online clinical trial of a 
self-help intervention for individuals with bipolar dis-
order, MoodSwings 2.0. In clinical research studies with 
high-risk populations, protecting patients and minimiz-
ing their clinical risk are paramount to most other con-
cerns. While this remains true for online mental health 
programs, the conceptualization of risk must be broad-
ened to include potential breaches of confidentiality 
related to online communications (such as unencrypted 
email), data privacy and security, risks of self-selection 
and diagnosis as well as the shortcomings of receiv-
ing psychoeducation and treatment at distance, from an 
impersonal website rather than a human being. It is now 
recognized that face-to-face psychosocial interventions, 
designed to have beneficial psychoactive effects, can at 
times inadvertently have adverse psychoactive effects. 
This paper will present our views on the unique ethical 
challenges presented by the MoodSwings 2.0 online pro-
gram for bipolar disorder, the lessons learned during our 
clinical trial, and potential future ethical considerations 
of online psychotherapeutic research.
Mood and the internet
A 2014 landmark study, coauthored by representa-
tives from the Core Data Science Team at Facebook as 
well as academicians at Cornell and Princeton, showed 
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convincing experimental evidence that users’ moods, 
measured by tendencies to post positive or negative sen-
timent, could at least in part be altered by manipulating 
the type and amount of emotional content in a user’s 
Facebook “News Feed” (Kramer et  al. 2014). In other 
words, website content may cogently shift and transform 
mood states independent of in-person meetings and 
exchanges. Simply, Facebook impacts mood.
So if online websites like Facebook that lack explicit 
mood-related messages or tools still have the capacity to 
shift mood, online mental health programs targeted to 
clinical populations like MoodSwings 2.0 with unequivo-
cal psychoeducation and techniques specifically designed 
to facilitate mood management may be uniquely posi-
tioned to do so. The MoodSwings 2.0 program is an 
internet-based psychoeducational and supportive inter-
vention for individuals with bipolar disorder, which is a 
chronic and disabling condition associated with frequent 
relapse and subsyndromal symptoms between episodes 
of mania, hypomania, or depression as well as signifi-
cant impairments in occupational and social functioning 
(Judd et al. 2008; Perlis et al. 2006). Its self-guided design 
complements and serves as an adjunct to clinical care 
from local psychiatrists, psychologists, and other men-
tal health professionals. The program’s content is based 
on the successful face-to-face group therapy program 
known as MAPS, which was adapted for online use and 
became known as MoodSwings.
A previous head-to-head trial of the MoodSwings pro-
gram had promising results (Lauder et al. 2015), leading 
to a technological upgrade and re-launch of the program 
now known as MoodSwings 2.0. The first trial compared 
a basic version of MoodSwings consisting of psychoedu-
cational materials and asynchronous discussion boards 
with a more interactive version that added skills-based 
cognitive behavioral therapy tools. Both groups showed 
clinically significant baseline to endpoint reductions 
in symptoms of mania and depression as well as other 
improvements in quality of life and functionality, and 
the more interactive version was superior to the basic 
version on long-term improvement in mania symptoms 
at 12-month follow-up. Additionally, MoodSwings 2.0 
integrated video-based content that enhanced didactic 
experiences for participants whenever possible as well as 
ensured that the overall program worked on a variety of 
different platforms including PCs, MacIntosh, Iphones, 
Ipads, and other tablets.
A number of internet-based programs have been 
evaluated as adjunctive treatments for bipolar disorder 
(Hidalgo-Mazzei et al. 2015; Faurholt-Jepsen et al. 2015). 
Many studies have shown promising results, including 
improvements in quality of life, symptom severity, social 
support, and medication adherence; however, further 
investigation is needed to establish the potential benefits 
of these programs through controlled trials as few pro-
grams have been evaluated against active control con-
ditions, noting that waitlist controls risk inflating effect 
sizes.
The MoodSwings 2.0 clinical trial, funded by the 
National Institute of Mental Health, is an international, 
randomized trial of three stepped levels of adjunctive 
treatment (Lauder et al. 2017) (see Fig. 1). Coordination 
of the clinical trial, which recruited three hundred partic-
ipants globally, was managed via a two-site international 
collaboration between the Stanford University School of 
Medicine in California and Deakin University in Aus-
tralia. Participants were subsequently assessed at 3, 6, 9, 
and 12  months via phone calls with trained study staff 
and online with standard instruments measuring mood 
symptoms, overall health status, and functioning, as well 
as quality of life in an effort to determine which compo-
nents of care may be most valuable.
The potential benefits for participants in programs 
like MoodSwings 2.0 are considerable. Accessing spe-
cialty care and evidence-based clinical information for 
bipolar disorder often proves challenging for patients, 
particularly those who may live in rural areas or have 
minimal financial resources (Zeber et al. 2009). Consum-
ers are often forced to seek in-person medication man-
agement from available medical doctors who may be 
excellent general practitioners but lack specialty training 
in the management of serious mental illnesses such as 
bipolar disorder. From the comfort of their own homes, 
MoodSwings participants were able to access psychoedu-
cational materials vetted by worldwide experts in bipolar 
disorder. Additionally, individuals interacted on discus-
sion boards, supported each other, and shared tips and 
techniques with other individuals from around the globe 
who struggle with similar mood symptomatology.
The challenge of ensuring privacy
Human subjects research projects generally must receive 
approval from local ethics committees, such as insti-
tutional review boards (IRBs) in the United States or 
human research ethics committees (HRECs) in Australia 
(Harriman and Patel 2014). The Stanford Encyclopedia 
of Philosophy’s chapter on Internet Research Ethics indi-
cates that privacy related to an individual’s confidentiality 
and anonymity as well as privacy and security of data is 
both exceptionally important when considering the eth-
ics of conducting research on the internet (Buchanan and 
Zimmer 2013). Since the global internet is by definition 
a public forum, ensuring privacy is uniquely challenging 
for clinical researchers.
In MoodSwings 2.0, participant’s privacy and confiden-
tiality were ensured in multiple ways. When a participant 
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first registered his or her interest in the study at http://
www.moodswings.net.au, he or she was asked to create a 
user name that did not resemble their own name or other 
names they may use on other websites such as discussion 
forums, Facebook, or Twitter. Previous experience from 
the MoodSwings 1.0 trial identified this possible issue, 
and this approach to prevent cross-site contamination 
was continued in MoodSwings 2.0. Further, participants 
and research staff communicated exclusively via an email 
messaging system that is internal to the website’s design. 
Participants were prohibited from using their personal 
email accounts for study communication and instead 
were always redirected to the internal messaging system. 
This maximized their privacy while enabling reliable and 
secure conversation between participants and study staff 
and is commonly used in online interventions (Klein 
et al. 2011).
Participants in MoodSwings 2.0 were able to com-
municate with other participants via one of three peer 
Discussion Boards, moderated by a researcher, depend-
ing on their randomization block. Here they were able 
to post interactive comments with other participants 
in the MoodSwings 2.0 study. While Board modera-
tors were primarily on call to ensure patient safety (dis-
cussed below), maintaining privacy and anonymity was 
also considered when moderating posts. Moderators read 
posts with an eye toward editing out information that 
could potentially identify a participant, such as physical 
location (i.e., address).
Given that this trial was officially funded by two NIH 
grants separately awarded to one US and one Australian 
institution, formal engagement with two separate ethical 
review boards (e.g., IRB, HREC) was necessary. The two 
coordinating sites for the trial ensured that their local 
ethics boards were tasked with both adhering to high 
ethical standards for conducting research with humans as 
well as reviewing and approving the same amendments 
at the same time for the overall global project. However, 
given the online and global nature of the project, neither 
ethical entity was resourced to address legal issues that 
could arise specific to any geographic jurisdiction other 
than their own. Instead, the ethical review boards that 
vetted this clinical trial were only able to protect factors 
such as participant privacy and safety pertaining to their 
own local jurisdictions—in this case, California and Gee-
long (Australia).
A recent open pilot trial of a mindfulness-focused 
intervention for late-stage bipolar disorder modeled 
procuring ethical approval in one national jurisdiction 
(Swinburne University, Australia) while focusing study 
Fig. 1 MoodSwings 2.0 study design. Figure shows flow for study procedures from first contact through intervention and follow-up
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recruitment efforts in another (Canada) (Murray et  al. 
2015). This seems an ideal, honest, and transparent 
model for multi-national internet intervention research 
initiatives. Participants can then be clearly informed in 
consenting documents that the project in which they are 
considering participation has been ethically vetted by 
only one institution in a given geographic and legal juris-
diction. The challenge within a consent document seems 
to then become how to practically inform potential par-
ticipants that regardless they are still themselves bound 
by the legal and ethical precedent in their own geograph-
ical jurisdiction.
Does privacy equal security?
Of course, there are obvious ethical quandaries in con-
fidently assuring patients of privacy when their research 
involvement occurs almost exclusively in a public setting 
like the internet. In some ways, as some bioethicists have 
suggested, the internet and other technologies may sig-
nificantly decrease a patient’s sense of privacy (Weber 
et al. 2012). However, other studies suggest that the per-
ceived potential to remain anonymous online may actu-
ally enhance a sense of privacy and safety (Griffiths et al. 
2006). Findings from one study examining the safety, pri-
vacy, and security of an online treatment for young con-
sumers recovering from early psychosis suggested that 
patients felt safe and trusted their experience on the web-
site (Gleeson et al. 2014). Since MoodSwings 2.0 collected 
information about participants’ subjective experiences of 
their research participation, it is similarly well-positioned 
to explore subjective perceptions of privacy. It must be 
noted however that a sense of privacy does not always 
equate with actual security and protection of privacy.
In the United States, the Health Insurance Portabil-
ity and Accountability Act of (1996) sets standards for 
Privacy and Security regarding Protected Health Infor-
mation, or PHI. Privacy and security of data in clinical 
research is always a high priority. Since MoodSwings 2.0 
operates on a virtual platform and collects data via the 
internet, careful considerations were made to protect and 
secure the data during negotiations with website develop-
ers. The MoodSwings 2.0 program adopts many common 
website security mechanisms including enterprise-based 
database encryption, Transport Layer Security (TLS)/
Secure Sockets Layer (SSL) as well as disaster recovery 
plans (Baker and Bufka 2011). MoodSwings 2.0 also runs 
and is backed up on the Digital Ocean Solid State Drive 
Cloud Server, similar to cloud servers utilized by large-
scale websites such as Pinterest and Facebook.
Dr. Google
Appropriate utilization of online resources depends in 
part on a suitable match between the resource and the 
participant’s problem. A challenge for online resources 
is that of self-diagnosis and self-selection for treatment. 
Bipolar disorder is notoriously complex to diagnose and 
has many differential diagnoses. A considerable amount 
of diagnostic instability characterizes all psychiatric 
diagnoses. And “externalizing” diagnoses such as bipo-
lar disorder may be more attractive to people than some 
“internalizing” diagnoses such as personality disorders. 
All of this is amplified by internet resources, which rely 
to a far greater extent on self-diagnosis and self-selection 
than face-to-face therapy and research. This entails a 
degree of risk and a corresponding ethical issue that will 
be a challenge for the field to resolve. MoodSwings 2.0 
used telephone interviews as a part solution to this issue, 
but many online trial websites do not have the resources 
to do this, and this is not feasible if the promise of scale-
independent roll out of such resources is to be realized.
Safety Red Flags and the limits of internet interventions 
for mental health
The MoodSwings 2.0 Red Flag Monitoring System (see 
Figs. 2, 3) was designed to identify and provide guidance 
to participants who may be approaching a clinical crisis. 
Although MoodSwings 2.0 was designed as an adjunct to 
local clinical care, a Red Flag System provides an ethical 
approach to fulfilling clinical responsibility to partici-
pants. When a participant signed consent and enrolled in 
the study, he or she was required to provide information 
for an individual who could be reliably contacted during 
an emergency. During regular online and phone assess-
ments, there were two fundamental ways to receive a 
system “Red Flag.” First, scores above a validated cut-off 
on various self-report or interview-based, mood-related 
measures generated a Red Flag, sending an automated 
internal email with instructions to the participant to con-
tact his or her health care provider. Most of these were 
the result of elevated overall scores on ratings of depres-
sion or mania, and in such cases study staff reassessed 
mood in 7 days. 
However, some Red Flags were generated as a result 
of clearly expressed suicidal ideation or intent. In these 
cases, a member of the study team called the participant, 
and if unsuccessful at making contact, the emergency 
contact. A Discussion Board Moderator also had discre-
tionary ability to generate a Red Flag for participants who 
expressed suicidal ideation, plan, or intent via a post. In 
this case, a participant was also contacted via phone.
The strengths and benefits of the MoodSwings 2.0 Red 
Flag Monitoring System included its benevolent objec-
tive to catch and help participants during clinical crisis by 
encouraging them to contact local care providers. Most 
of the time, the study team agreed that the Red Flag sys-
tem was helpful for participants and researchers alike. 
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Fig. 2 MoodSwings 2.0 Red Flag Monitoring System flowchart: self-assessment and discussion board components. Figure includes detailed model 
for Red Flag Monitoring System designed to identify via routine self-report methods study participants at high risk for suicidal behavior and provide 
guidance for services and care. Participants are also identified as high risk if the content of their discussion board posts is deemed concerning by 
study monitors
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However, there were noteworthy exceptions, where its 
implicit constraints should be underscored. For example, 
if study staff are not able to connect via phone for many 
days or at all with a participant or emergency contact, 
what steps should be taken to ensure patient safety? This is 
an ethical gray area connected to online interventions. For 
how long should study staff continue to attempt contact? 
What if a participant became agitated by the MoodSwings 
2.0 automated email communication, which could occur 
as frequently as once per week if he or she is mid-episode?
The identification of participants who have been 
“flagged” as a result of general symptomatology or sui-
cidal ideation also underscores the global nature of 
online internationally accessible projects as well as the 
limitations of practicing “distance therapy” (DeAngeles 
2012). Participants in most cases lived in localities physi-
cally distant from Palo Alto or Geelong, the two study 
coordinating sites. Study staff were unlikely to be familiar 
with available crisis resources on a local level. Moreover, 
local resources were often scarce. During the course of 
the trial, the team sought to identify specific suicide hot-
lines or services for every country represented by active 
participants. For several remote countries where par-
ticipants had enrolled, this proved impossible. This issue 
also underscored the difference between the quality and 
depth of the therapeutic linkages and relationships possi-
ble in online self-help forums and face-to-face trials, and 
the consequent feasibility of intervention in such diverse 
circumstances.
Managing risk: protecting the interests of the MoodSwings 
2.0 clinical research team
In addition to protecting patients, the interests of clini-
cal researchers operating from a virtual and physical 
Fig. 3 MoodSwings 2.0 Red Flag Monitoring System flowchart: interview components. Figure includes detailed model for Red Flag Monitoring 
System designed to identify via routine phone interview methods study participants at high risk for suicidal behavior and provide guidance for 
services and care
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distance must be carefully considered. For example, there 
are inherent limitations when primary communication 
with participants takes place via electronic modalities 
such as email or discussion boards or phone-based clini-
cal interviews. The most important safeguard for both 
the research team and participants was to emphasize 
repeatedly the adjunctive nature of the MoodSwings 2.0 
Program. Participants as well as members of the study 
team were frequently reminded first and foremost that 
the MoodSwings 2.0 program was not a substitute for 
ongoing face-to-face supervision and consultation with 
health care providers. Study staff were prohibited from 
monitoring individual participant interaction with the 
MoodSwings 2.0 program or responding in personal-
ized or individualized ways to participant input, except in 
cases of Red Flags.
As a further ethical check, a Data Safety Moni-
toring Board (DSMB) was convened specifically for 
MoodSwings 2.0, composed of ethicists and research-
ers from around the globe and with the sole purpose of 
identifying and managing specific risks for participants. 
DSMB discussions largely encompassed issues related to 
patient and data privacy and security described earlier 
in this opinion. DSMB members have also discussed the 
complexities of collecting information on adverse events 
(AEs) and serious adverse events (SAEs) frequently 
aggregated by researchers during clinical trials. Bioethi-
cists are already uncertain about the quantity and type 
of AE and SAE information to solicit from participants 
during psychotherapy intervention trials (Czaja et  al. 
2006), and this question is even more complex within the 
context of a clinical trial of an online psychosocial inter-
vention like MoodSwings 2.0. If AE and SAE data are sys-
tematically collected during patient assessments, can any 
be reliably attributed to passive interactions with online 
psychoeducational materials or discussion board posts, 
especially when levels of involvement with the web-
site vary significantly from participant to participant? If 
a study interview reveals an AE or SAE that represents 
an ongoing, real-time crisis unrelated to bipolar disor-
der, what is the corresponding ethical responsibility of 
the interviewer? Should this information generate a Red 
Flag? From one perspective, it seems unethical to request 
and record information from participants about sensi-
tive life events without any intent of clinical follow-up or 
planned utilization of the data. From another, it seems 
unethical not to probe.
From an ethical standpoint, it is also important to con-
sider that internet interventions for mental health may 
not always prove helpful for their consumers. A recent 
analysis of negative effects from a pooled sample of par-
ticipants in four separate internet-based cognitive behav-
ioral therapy interventions for anxiety or depression 
found that 9.3% of participants reported at least one 
potentially treatment-related adverse event (Rozental 
et al. 2015). Subsequent qualitative content analysis sug-
gested that gaining knowledge and awareness may have 
led to feeling anxious or depressed during treatment for 
some, while others indicated frustration and dysphoria 
related to persistent struggles implementing the content 
on the available internet platform. Even more salient are 
the recently published results from the MONARCA I 
trial, which focused on daily, electronic, self-monitoring 
in bipolar disorder using a randomized, placebo-con-
trolled design (Faurholt-Jepsen et al. 2015). Interestingly, 
for participants receiving the intervention, depression 
scores were higher when compared with those of partici-
pants receiving a control condition. The authors suggest 
that the act of daily monitoring of symptoms of depres-
sion may have helped prolong them by continually draw-
ing awareness and possibly increasing rumination (Berk 
and Parker 2009).
Managing expectations
One unanticipated challenge encountered during the 
MoodSwings 2.0 trial involved managing the expecta-
tions of different entities including website develop-
ers, clinical researchers, and research participants from 
around the world, as these were sometimes at odds. 
Similarly, website developers functioning within a for-
profit environment may not be sensitive to budget and 
personnel constraints faced by smaller-scale sites like 
MoodSwings 2.0 funded by not-for-profit sources. 
MoodSwings 2.0 participants are by definition individu-
als who actively engage in online activities. Such con-
sumers of the internet often have expectations for the 
real-time availability and functionality of chosen web-
sites. Participants may have more interactive familiar-
ity with websites such as Facebook, Pinterest, or Twitter 
which have capital and scope to provide technologically 
sophisticated online experiences. A user expects to be 
able to access his Facebook news feed or Pinterest board 
on demand. Expectations for these websites are focused 
on their ability to provide immediate and uninterrupted 
entertainment. Further, a majority of internet consum-
ers seek some kind of health information on the inter-
net (Fox and Jones 2009), and their expectations are for 
sound information that they can use to inform health 
care decisions.
Individuals enrolled in an online program that provides 
treatment for mental illness, like MoodSwings 2.0 for 
bipolar disorder, likely possess slightly modified expecta-
tions for their virtual experience. An individual visiting 
a website like http://www.moodswings.net.au is likely in 
search of more than simple entertainment. It seems logi-
cal that participants have an ethical right to expect access 
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to discriminating psychoeducation on bipolar disorder 
informed by the scientific evidence base as well as access 
to moderated and safe peer discussion forums.
In turn, the clinical research staff has the right to 
expect participants to safely and responsibly use the 
MoodSwings 2.0 program, which is designed to be an 
adjunct to in  vivo clinical care. The ethical “catch” is 
that the research team has no way to globally enforce or 
verify that participants are seeking care on a local level. 
And sometimes an unexpected escalation of mood or 
psychotic symptoms during a bipolar episode may make 
it very difficult for a participant to physically reach out 
to a medical doctor or psychotherapist for immediate 
help. In some cases, participants instead opted to post 
to a MoodSwings 2.0 Discussion Board or send emails to 
research staff via the internal messaging system. Within 
the context of the trial, these instances generated Red 
Flags, and participants were contacted within days. It is 
vital that participants are informed and reminded about 
the limitations of entirely self-help online interventions 
and the link with their treating clinician is reinforced. 
Future online interventions need to be cognizant of mod-
erating participant expectations and developing clear 
protocols to address patient distress.
Conclusions
One commentary suggests that the “speed at which the 
internet can spawn new ethical dilemmas has thus far 
understandably outpaced the rate at which organized 
psychology can develop ethical principles in a careful, 
deliberative fashion” (Humphreys et al. 2000). The devel-
opment of the MoodSwings 2.0 program and its accom-
panying trial has represented a collision of many different 
“worlds,” including proprietary software development 
companies, academics from the United States and Aus-
tralia, clinical researchers accustomed to studies that 
enroll human subjects in-person, ethics committees with 
norms developed around face-to-face studies, and par-
ticipants with serious mental illnesses from around the 
globe. In order for online interventions for mental health 
to succeed as either clinical trials or reputable clinical 
resources, risks and expectations of all involved need to 
be carefully considered with a focus on ethical integrity.
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